Coleman RL - Search Results

1

MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer.

Wu Y, Huang J, Ivan C, Sun Y, Ma S, Mangala LS, Fellman BM, Urbauer DL, Jennings NB, Ram P, Coleman RL, Hu W, Sood AK. Wu Y, et al. Among authors: coleman rl. Gynecol Oncol. 2021 Oct;163(1):181-190. doi: 10.1016/j.ygyno.2021.08.003. Epub 2021 Aug 11. Gynecol Oncol. 2021. PMID: 34391578 Free PMC article.

2

Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy.

Coleman RL, Keeney ED, Freedman RS, Burke TW, Eifel PJ, Rutledge FN. Coleman RL, et al. Gynecol Oncol. 1994 Oct;55(1):29-35. doi: 10.1006/gyno.1994.1242. Gynecol Oncol. 1994. PMID: 7959262

3

Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma.

Lea JS, Coleman RL, Garner EO, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Among authors: coleman rl. Gynecol Oncol. 2003 Dec;91(3):558-62. doi: 10.1016/j.ygyno.2003.08.020. Gynecol Oncol. 2003. PMID: 14675676

4

Retrospective analysis of weekly topotecan as salvage therapy in relapsed ovarian cancer.

Bhoola SM, Coleman RL, Herzog T, Morris R, Bryant C, Estes JM, Alvarez RD. Bhoola SM, et al. Among authors: coleman rl. Gynecol Oncol. 2004 Dec;95(3):564-9. doi: 10.1016/j.ygyno.2004.08.026. Gynecol Oncol. 2004. PMID: 15581964

5

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.

Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL. Rao GG, et al. Among authors: coleman rl. Gynecol Oncol. 2005 Jan;96(1):168-72. doi: 10.1016/j.ygyno.2004.09.009. Gynecol Oncol. 2005. PMID: 15589596 Clinical Trial.

6

Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.

Sood AK, Coleman RL, Wolf JK, Gershenson DM. Sood AK, et al. Among authors: coleman rl. Expert Opin Pharmacother. 2005 Jun;6(7):1269-75. doi: 10.1517/14656566.6.7.1269. Expert Opin Pharmacother. 2005. PMID: 15957979 No abstract available.

7

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.

Coleman RL, Broaddus RR, Bodurka DC, Wolf JK, Burke TW, Kavanagh JJ, Levenback CF, Gershenson DM. Coleman RL, et al. Gynecol Oncol. 2006 Apr;101(1):126-31. doi: 10.1016/j.ygyno.2005.09.041. Epub 2005 Nov 3. Gynecol Oncol. 2006. PMID: 16271384 Clinical Trial.

8

The role of maintenance therapy and novel taxanes in ovarian cancer.

Herzog TJ, Coleman RL, Markman M, Cella D, Thigpen JT. Herzog TJ, et al. Among authors: coleman rl. Gynecol Oncol. 2006 Aug;102(2):218-25. doi: 10.1016/j.ygyno.2005.12.001. Epub 2006 Feb 7. Gynecol Oncol. 2006. PMID: 16460787 Review.

9

Total laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience.

Ramirez PT, Slomovitz BM, Soliman PT, Coleman RL, Levenback C. Ramirez PT, et al. Among authors: coleman rl. Gynecol Oncol. 2006 Aug;102(2):252-5. doi: 10.1016/j.ygyno.2005.12.013. Epub 2006 Feb 10. Gynecol Oncol. 2006. PMID: 16472844

10

Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer.

Ramirez PT, Slomovitz BM, McQuinn L, Levenback C, Coleman RL. Ramirez PT, et al. Among authors: coleman rl. Gynecol Oncol. 2006 Dec;103(3):888-90. doi: 10.1016/j.ygyno.2006.05.021. Epub 2006 Jun 27. Gynecol Oncol. 2006. PMID: 16806436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

612 results

Search Page

Filters